Sigma1 receptor 1 (Sigma1R) is a unique ER-resident chaperone protein that functions as a ligand-operated molecular chaperone. It plays critical roles in calcium signaling, lipid metabolism, and protein quality control. Sigma1R has emerged as a significant therapeutic target in neurodegenerative diseases including ALS, AD, PD, and Huntington's disease due to its involvement in ER stress response, mitochondrial function, and neuroprotection.
- Length: 223 amino acids
- Molecular Weight: ~25,340 Da
- Topology: Single-pass membrane protein (type I)
¶ Domain Architecture
- N-terminal ER Luminal Domain: Residues 1-180
- Contains the chaperone domain
- Ligand-binding pocket
- C-terminal ER Retention Signal: KDEL motif (residues 220-223)
- Trimeric Assembly: Forms functional trimers
- Ligand-Binding Site: Hydrophobic pocket in luminal domain
- Ca²⁺ Binding: Regulatory Ca²⁺-binding site
- D91G: Juvenile ALS, loss of function
- L95frameshift: ALS, truncated protein
- E102Q: ALS, impaired chaperone activity
Sigma1R acts as a ligand-operated chaperone that:
- Stabilizes protein conformations
- Prevents aggregation of misfolded proteins
- Assists in ER-associated protein quality control
- ER-Mitochondria Tethering: Forms mitochondria-associated ER membranes (MAM) complexes
- Ca²⁺ Transfer: Regulates Ca²⁺ flux from ER to mitochondria
- IP₃R Modulation: Interacts with IP₃ receptors
- Sterol Transport: Involved in cholesterol homeostasis
- Lipid Raft Organization: Modulates membrane lipid composition
- Phospholipid Synthesis: Influences phospholipid metabolism
- Neuroprotection: Reduces oxidative stress
- Angiogenesis: Promotes blood vessel formation
- Cell Proliferation: Regulates cell cycle
- ER Stress: Sigma1R mutations cause chronic ER stress
- Mitochondrial Dysfunction: Impaired Ca²⁺ transfer to mitochondria
- Motor Neuron Degeneration: Loss of proteostasis
- Aggregates: Co-localization with TDP-43 inclusions
- APP Processing: Modulates β- and γ-secretase activity
- Aβ Toxicity: Protects against Aβ-induced neurotoxicity
- Calcium Dysregulation: Restores Ca²⁺ homeostasis
- Synaptic Function: Preserves synaptic plasticity
- α-Synuclein: Interacts with α-synuclein aggregates
- Mitochondrial Protection: Maintains mitochondrial function
- Dopaminergic Neurons: Protects against degeneration
- Mutant Huntingtin: Interacts with mHTT aggregates
- Transcription Regulation: Modulates gene expression
- ER Stress: Alleviates ER stress in HD models
- Loss of Chaperone Function: Mutant Sigma1R fails to handle protein aggregates
- Mitochondrial Calcium Dysregulation: Impaired energy metabolism
- ER Stress: Chronic UPR activation
- Oxidative Stress: Increased ROS production
- Synaptic Dysfunction: Impaired neurotransmission
| Drug | Mechanism | Status |
|------|-----------|--------|
| Preladenant | A₂A antagonist/Sigma1R modulator | Parkinson's (Phase 2) |
| SA4503 | Sigma1R agonist | Neuropathic pain |
| Donepezil | Sigma1R binding | Approved (AD) |
| Fluvoxamine | Sigma1R agonist | Approved (OCD) |
- NE-100: Selective antagonist, preclinical
- BD-1063: Sigma1R antagonist, neuroprotection research
- NCT05663437: Sigma1R agonists in ALS (recruiting)
- NCT05308901: Sigma1R modulators in AD (Phase 2)
- Small Molecule Modulators: Precision medicine approaches
- Gene Therapy: AAV-delivered Sigma1R
- Protein Replacement: Recombinant Sigma1R
| Partner |
Interaction Type |
Relevance |
| IP₃R |
Ca²⁺ channel modulation |
ER-mitochondria signaling |
| VDAC |
Ion channel |
Mitochondrial function |
| BiP |
Chaperone complex |
ER stress response |
| Grp94 |
Chaperone |
Protein folding |
| Sigmat |
Hetodimer formation |
Functional complex |
| TDP-43 |
Aggregation |
ALS pathology |
| mHTT |
Aggregate interaction |
Huntington's disease |